Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and diabetes management: What should be considered?
Antonio Ceriello, Anca Pantea Stoian, Manfredi Rizzo
Diabetes Research and Clinical Practice (2020) Vol. 163, pp. 108151-108151
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 935
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
Ashish Kumar, Anil Arora, Praveen Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 4, pp. 535-545
Open Access | Times Cited: 737
Metformin in COVID-19: A possible role beyond diabetes
Swati Sharma, Avik Ray, Balakrishnan Sadasivam
Diabetes Research and Clinical Practice (2020) Vol. 164, pp. 108183-108183
Open Access | Times Cited: 194
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Cyril P. Landstra, Eelco J.P. de Koning
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 178
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports
André Scheen, Michel Marre, Charles Thivolet
Diabetes & Metabolism (2020) Vol. 46, Iss. 4, pp. 265-271
Open Access | Times Cited: 143
COVID-19 in people living with diabetes: An international consensus
A. Enrique Caballero, Antonio Ceriello, Anoop Misra, et al.
Journal of Diabetes and its Complications (2020) Vol. 34, Iss. 9, pp. 107671-107671
Open Access | Times Cited: 126
Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19
Aditi Banerjee, Steven J. Czinn, Russel J. Reıter, et al.
Life Sciences (2020) Vol. 255, pp. 117842-117842
Open Access | Times Cited: 118
The management of coronavirus disease 2019 (COVID‐19)
Jialin Liu, Siru Liu
Journal of Medical Virology (2020) Vol. 92, Iss. 9, pp. 1484-1490
Open Access | Times Cited: 99
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
Luis M. Pérez-Belmonte, José D. Torres‐Peña, Maria D. López‐Carmona, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 96
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Inés Valencia, Concepción Peiró, Óscar Lorenzo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 95
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, et al.
Diabetes Care (2020) Vol. 43, Iss. 7, pp. 1427-1432
Open Access | Times Cited: 81
COVID-19: Diabetes Perspective—Pathophysiology and Management
Siva Dallavalasa, SubbaRao V. Tulimilli, Prakash Janhavi, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 184-184
Open Access | Times Cited: 24
The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?
Cyrielle Holuka, Myriam P. Merz, Sara B. Fernandes, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5094-5094
Open Access | Times Cited: 57
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study
Anca Pantea Stoian, Mihaela Pricop‐Jeckstadt, Adrian Pană, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Optimal Control of Mathematical modeling of the spread of the COVID-19 pandemic with highlighting the negative impact of quarantine on diabetics people with Cost-effectiveness
Abdelfatah Kouidere, Lahcen El Youssoufi, Hanane Ferjouchia, et al.
Chaos Solitons & Fractals (2021) Vol. 145, pp. 110777-110777
Open Access | Times Cited: 51
Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge
Domenico Nuzzo, Sonya Vasto, Luca Scalisi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1947-1947
Open Access | Times Cited: 49
Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel
Wael Al Mahmeed, Khalid Al‐Rasadi, Yajnavalka Banerjee, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 45
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
Rosaria Vincenza Giglio, Νικόλαος Παπάνας, Ali A. Rizvi, et al.
Medicina (2022) Vol. 58, Iss. 10, pp. 1475-1475
Open Access | Times Cited: 37
Issues for the management of people with diabetes and COVID-19 in ICU
Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 49
Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes
Anca Pantea Stoian, Peter P. Tóth, Péter Kempler, et al.
International Journal of Clinical Practice (2020) Vol. 75, Iss. 2
Open Access | Times Cited: 41
Manejo de la diabetes mellitus en tiempos de COVID-19
José Paz‐Ibarra
ACTA MEDICA PERUANA (2020) Vol. 37, Iss. 2
Open Access | Times Cited: 40
The Role of Endothelium in COVID-19
Mihaela Ionescu, Anca Pantea Stoian, Manfredi Rizzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11920-11920
Open Access | Times Cited: 36
Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
Bao Sun, Shiqiong Huang, Jiecan Zhou
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 34
Metformin: Sex/Gender Differences in Its Uses and Effects—Narrative Review
Ιoannis Ilias, Manfredi Rizzo, Lina Zabulienė
Medicina (2022) Vol. 58, Iss. 3, pp. 430-430
Open Access | Times Cited: 23
COVID-19: the endocrine opportunity in a pandemic
Subhankar Chatterjee, Ritwik Ghosh, Payel Biswas, et al.
Minerva Endocrinologica (2020) Vol. 45, Iss. 3
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top